JPO Decides Lipitor Crystal Form “Valid”, Sandoz Calls for Appeal

January 30, 2012
On action brought on by Sandoz in November 2011 seeking the annulment of a patent covering crystalline forms of Lipitor (atorvastatin calcium hydrate; owned by Pfizer Japan and Astellas Pharma), for which generic versions have been launched by market entrants...read more